Болезнь кавасаки у детей г. Киева. Анализ 23 случаев
DOI:
https://doi.org/10.15574/SP.2018.89.116Ключевые слова:
болезнь Кавасаки, дети, коронарит, аневризмы коронарных сосудов, лихорадка, внутривенный человеческий иммуноглобулинАннотация
Представлено наибольшее в Украине наблюдение болезни Кавасаки (БК) у детей — 23 клинических случая в г. Киеве. Частота полной БК составила 56%, неполной — 44%. Частота поражений коронарных сосудов составила 33% и была наивысшей у детей первого года жизни — 83%. Проанализированы симптомы, лабораторные проявления БК. Описаны особенности постановки диагноза неполной БК. Рассчитана распространенность БК в г. Киеве в 2016 году — 4,6 на 100 000 детей до 5 лет жизни и ожидаемая распространенность БК для Украины в 2016 году — 103 случая.Библиографические ссылки
Banadyha NV. (2014). Case of Kawasaki syndrome. Sovremennaya pediatriya. 4: 40–42.
Berezhnyi VV, Sovtus KhM, Bondarets YuI. (2017). Kawasaki's disease in children. Features of diagnosis and treatment (lecture). Sovremennaya pedyatriya. 3: 38–44.
Bondarenko AV, Chernyshova LI, Holovatiuk IV et al. (2013). Features of clinical course and diagnostics of incomplete syndrome Kawasaki. Sovremennaya pedyatriya. 4: 165–168.
Haiduk TA, Shostakovych-Koretska LR. (2009). Clinical case of Kawasaki disease in a 7-month infant. Medychni perspektyvy. 14(4): 24–28.
Dorofeeva H.D. (1982). Case of Kawasaki disease (mucosal-skin-lymphatic syndrome) in a boy of 6 years. Pedyatr. 4: 65–66.
Zerbino DD, Kuryliak OB, Boiko OI, Hoshovska II. (2014). Kawasaki disease: 4-years old boy with coronary aneurisms. Praktychna anhiolohiia. 3(66): 9–12.
Kuryliak OB. (2010). Kawasaki disease in children (cases). Pediatrics, obstetrics and gynecology. 1: 43–46.
Maidannyk VH, Mytiuraeva-Korneiko YA. (2015). Kawasaki disease in childhood. Kiyv: Lohos.
Shostakovych-Koretskaia LR, Budaeva YV. (2013). Kawasaki's syndrome as a cause of prolonged fever in children. Aktualnaia infektolohyia. 1: 104–107.
Amano S, Hazama F, Kubagawa H et al. (1980). General pathology of Kawasaki disease. On the morphological alterations corresponding to the clinical manifestations. Acta Pathol Jpn. 30: 681. PMid:7446109
Belay ED, Maddox RA, Holman RC et al. (2006). Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994–2003. Pediatr Infect Dis. 25: 245–9. https://doi.org/10.1097/01.inf.0000202068.30956.16; PMid:16511388
Burgner D, Davila S, Breunis WB et al. (2009). A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genetics. 5: 1000319. https://doi.org/10.1371/journal.pgen.1000319; PMid:19132087 PMCid:PMC2607021
Burgner D, Hamden A. (2005). Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis. 9: 185. https://doi.org/10.1016/j.ijid.2005.03.002; PMid:15936970
Burns JC, Cayan DR, Tong G et al. (2005). Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology. 16: 220. https://doi.org/10.1097/01.ede.0000152901.06689.d4; PMid:15703537 PMCid:PMC2894624
Burns JC, Glode MP. (2004). Kawasaki syndrome. Lancet. 364: 533. https://doi.org/10.1016/S0140-6736(04)16814-1
Chen S, Dong Y, Yin Y et al. (2013). Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart. 99: 76–82. https://doi.org/10.1136/heartjnl-2012-302126; PMid:22869678
Dergun M, Kao A, Hauger SB et al. (2005). Familial occurrence of Kawasaki syndrome in North. Pediatr Adolesc Med. 159: 876. https://doi.org/10.1001/archpedi.159.9.876; PMid:16143748 PMCid:PMC2910318
Diagnostic guidelines for Kawasaki disease. 5th edn. Japan Kawasaki Disease Research Committee (2002). Tokyo.
Du ZD, Zhao D, Du J et al. (2007). Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004. Pediatr Infect Dis J. 26: 449. https://doi.org/10.1097/01.inf.0000261196.79223.18; PMid:17468660
Fischer TK, Holman RC, Yorita KL et al. (2007). Kawasaki syndrome in Denmark. Pediatr Infect Dis J. 26: 411. https://doi.org/10.1097/01.inf.0000259964.47941.00; PMid:17468651
Galeotti C, Kaveri SV, Cimaz R, Koné-Paut I et al. (2016). Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease. Drug Discov Today. 21(11): 1850–1857. https://doi.org/10.1016/j.drudis.2016.08.004; PMid:27506874
Hirata S, Nakamura Y, Yanagawa H. (2001). Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr. 90: 40. https://doi.org/10.1111/j.1651-2227.2001.tb00253.x; PMid:11227331
Holman RC, Curns AT, Belay ED et al. (2003). Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics. 112: 495. https://doi.org/10.1542/peds.112.3.495; PMid:12949272
Huang WC, Huang LM, Chang IS et al. (2009). Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics. 123: 401. https://doi.org/10.1542/peds.2008-2187; PMid:19237439
Jennette JC, Falk RJ. (2007). The role of pathology in the diagnosis of systemic vasculitis. Clin Exp Rheumatol. 25: 52.
Kanecki K, Mikołajczyk M, Tyszko P. (2016). Kawasaki disease: increasing incidence in Poland. Scandinavian Journal of Rheumatology. 45; 1: 82–83. https://doi.org/10.3109/03009742.2015.1085082; PMid:26399391
Kao AS, Getis A, Brodine S, Burns JC. (2008). Spatial and temporal clustering of Kawasaki syndrome cases. Pediatr Infect Dis J. 27: 981. https://doi.org/10.1097/INF.0b013e31817acf4f; PMid:18852687 PMCid:PMC2870532
Kawasaki T. (1967). Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 16(3): 178. PMid:6062087
McCrindle et al. (2017). Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease. Circulation: 135.
Nakamura Y, Yashiro M, Uehara R et al. (2010). Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey. J Epidemiol. 20(4): 302. https://doi.org/10.2188/jea.JE20090180; PMid:20530917 PMCid:PMC3900790
Newburger JW, Takahashi M, Gerber MA et al. (2004). Diagnosis, treatment, and longterm management of Kawasaki disease. Circulation. 110: 2747–71. https://doi.org/10.1161/01.CIR.0000145143.19711.78; PMid:15505111
Onouchi Y, Ozaki K, Burns JC et al. (2012). A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet. 44: 517–21. https://doi.org/10.1038/ng.2220; PMid:22446962
Schiller B, Fasth A, Bjorkhem G et al. (1995). Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr. 84(7): 769–774. https://doi.org/10.1111/j.1651-2227.1995.tb13753.x; PMid:7549295
Son MB, Gauvreau K, Ma L et al. (2009). Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics. 124: 1. https://doi.org/10.1542/peds.2008-0730; PMid:19564276
Takahashi K, Oharaseki T, Yokouchi Y. (2011). Pathogenesis of Kawasaki disease. Clin Exp Immunol. 164; Suppl 1: 20. https://doi.org/10.1111/j.1365-2249.2011.04361.x; PMid:21447126 PMCid:PMC3095860
Tamburlini G, Strinati R, Cadorini S et al. (1984). A two-year survey of mucocutaneous lymph node syndrome in northeastern Italy. Epidemiological and clinical findings. Helv. Paediatr. Acta. 39: 319–329. PMid:6543845
Tremoulet AH, Best BM, Song S et al. (2008). Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 153: 117–21. https://doi.org/10.1016/j.jpeds.2007.12.021; PMid:18571548 PMCid:PMC2526555